$STZ

Constellation Brands (STZ) Q2 Beats Estimates but Full-Year EPS

Constellation Brands (STZ) reported Q2 earnings of $3.74 per share on $2.63B revenue, beating estimates. The company lowered full-year EPS guidance to $11.20-$11.90, below market expectations. STZ offers a 3.66% dividend yield with a 38% payout ratio and 8.4% 3-year growth. GuruFocus rates STZ undervalued with a GF Score of 59/100, noting strong profitability but weak momentum. Institutional investors show cautious sentiment.

Original reporting
Published Oct 6, 2026, 9:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 10:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STZ
Bearish
high confidence
Mentioned
$STZ
Relevance
8/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$STZBearishMed
01

Why it matters

Guidance below consensus may trigger a sell‑off, but the dividend yield and valuation discount could attract long‑term income investors.

02

Market read

Earnings beat offset by weaker guidance creates mixed sentiment; short‑term downside risk with potential long‑term dividend appeal.

03

What to watch

Insider sales are modest; dividend safety and valuation gap may attract income‑focused investors.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Constellation Brands is a $19.8 B consumer defensive company with a diversified alcoholic beverage portfolio and a 3.66% dividend yield.

Company-level read

Ticker impact

$STZBearishHigh confidence
Context

Constellation Brands reported Q2 earnings that beat estimates but issued full-year EPS guidance below consensus, impacting its stock price.

Expected impact

likely pressure as market prices in weaker full-year EPS outlook

Evidence & confidence

Guidance below expectations is a fresh, material fact for a large‑cap consumer defensive stock; investors typically react negatively to lowered earnings forecasts.

Market effects

May weigh on consumer defensive and alcoholic beverage peers as guidance concerns spread.

U.S. market focus; limited regional spillover.

Modest, confined to beverage sector investors.

Counterpoint

The earnings beat and strong dividend yield could support a buy‑the‑dip thesis despite guidance miss.

Key entities

  • Constellation Brands Inc.

    U.S. listed consumer defensive beverage producer (ticker STZ).

Related articles

$STZHigh

STZ Stock Falls As Modelo And Corona Lose Volume, Full-Year Profit Outlook Holds

Constellation Brands (STZ) reaffirmed its fiscal 2027 earnings guidance of $11.20 to $11.90 per share, with organic net sales and beer net sales expected to range from -1% to +1%. The company also announced the acquisition of SpikedAde for $75 million, with potential earnouts up to $278 million. STZ stock has fallen 16% year-to-date, despite positive retail sentiment on Stocktwits.

$STZMedAI 8/10

Constellation Brands buys RTD start-up SpikedAde

Constellation Brands acquired a 100% stake in SpikedAde, a vodka-based RTD brand, for $75m, with up to $278m in performance-based payments. SpikedAde, founded in 2024, has a presence in the eastern US. Constellation plans to expand its distribution using its marketing and sales capabilities.

$STZHighAI 8/10

Constellation Brands (STZ) Q2 Earnings Beat Supports Dividend Su

Constellation Brands (STZ) reported Q2 earnings with Non-GAAP EPS of $3.74, beating estimates by $0.19, and revenue of $2.63B, surpassing projections by $90M. The company maintains a 3.66% dividend yield with a 38% payout ratio and 8.4% 3-year dividend growth. STZ's GF Score is 59/100, indicating moderate financial health. Institutional activity is mixed, with some gurus trimming positions while others add.